Tissue Engineering Onboard the International Space Station

3:15 PM - 4:15 PM, Tuesday, June 4,2019 ・ 111AB, Level 100
Over the past few years, both the National Institutes of Health and the National Science Foundation have put forth large quantities of funding towards life science research onboard the International Space Station U.S. National Laboratory. Why are these funding agencies investing millions into station research? How does the microgravity environment of the space station contribute towards unlocking concepts that could accelerate drug development and design? What are these implications for the drug development community?
Moderator
photo
Commercial Innovation Officer
Space Tango
Speakers
photo
Commercial Innovation Officer
Space Tango
photo
Scientific Program Manager
National Center for Advancing Translational Sciences (a branch of the NIH)
photo
Physician-Scientist in Neonatology
Children’s Hospital of Philadelphia
photo
Program Manager, Biomedical Engineering Program
National Science Foundation
photo
Ph.D. Candidate, Department of Bioengineering
University of Pennsylvania